Stay updated on ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial
Sign up to get notified when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.

Latest updates to the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added; the funding-status notice and the old Revision: v3.4.1 entry were removed.SummaryDifference0.3%

- Check21 days agoChange DetectedA system-wide notice about potential data delays due to a lapse in government funding has been added, with links to cc.nih.gov and opm.gov. The page version has been updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedShow glossary option added and minor wording tweaks to QC-related labels and revision references. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4, indicating a minor maintenance update.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section updated with new site listings for US (California, Colorado, Connecticut, Florida, Kansas, Michigan, Nevada, New York, North Carolina, Pennsylvania, Virginia, Wisconsin) and Canada (Alberta, Ontario). The revision label changed from v3.3.2 to v3.3.3 and the page's location headings were reorganized (removing the separate state/province subheadings).SummaryDifference1%

- Check85 days agoChange DetectedFooter shows Revision: v3.3.2, replacing v3.3.1; no study content or functionality was changed.SummaryDifference0.0%

Stay in the know with updates to ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.